ADCT logo

ADCT
Adc Therapeutics SA

1,249
Mkt Cap
$484.04M
Volume
542,053.00
52W High
$4.98
52W Low
$1.13
PE Ratio
-3.21
ADCT Fundamentals
Price
$3.86
Prev Close
$3.81
Open
$3.85
50D MA
$4.04
Beta
1.55
Avg. Volume
923,130.70
EPS (Annual)
-$1.12
P/B
-2.61
Rev/Employee
$421,538.86
$626.76
Loading...
Loading...
News
all
press releases
ADC Therapeutics SA $ADCT Stock Holdings Raised by JPMorgan Chase & Co.
JPMorgan Chase & Co. grew its position in ADC Therapeutics SA (NYSE:ADCT - Free Report) by 865.3% in the third quarter, according to its most recent 13F filing with the Securities and Exchange...
MarketBeat·5d ago
News Placeholder
More News
News Placeholder
Insider Selling: ADC Therapeutics (NYSE:ADCT) Major Shareholder Sells 169,265 Shares of Stock
ADC Therapeutics SA (NYSE:ADCT - Get Free Report) major shareholder Redmile Group, Llc sold 169,265 shares of the company's stock in a transaction that occurred on Wednesday, April 1st. The shares...
MarketBeat·12d ago
News Placeholder
Insider Selling: ADC Therapeutics (NYSE:ADCT) Major Shareholder Sells 196,229 Shares of Stock
ADC Therapeutics SA (NYSE:ADCT - Get Free Report) major shareholder Redmile Group, Llc sold 196,229 shares of the company's stock in a transaction on Tuesday, March 31st. The stock was sold at an...
MarketBeat·12d ago
News Placeholder
Insider Selling: ADC Therapeutics (NYSE:ADCT) Major Shareholder Sells $8,641,179.68 in Stock
ADC Therapeutics SA (NYSE:ADCT - Get Free Report) major shareholder Redmile Group, Llc sold 2,634,506 shares of ADC Therapeutics stock in a transaction that occurred on Thursday, April 2nd. The stock was sold at an average price of $3.28, for a total transaction of $8,641,179.68. Following the...
MarketBeat·12d ago
News Placeholder
ADC Therapeutics Announces New Employee Inducement Grant
ADC Therapeutics Announces New Employee Inducement Grant ADC Therapeutics Announces New Employee Inducement Grant PR Newswire LAUSANNE, Switzerland, April 1, 2026 LAUSANNE, Switzerland, April 1, 2026...
PR Newswire·13d ago
News Placeholder
Is Acumen Pharmaceuticals (ABOS) Stock Outpacing Its Medical Peers This Year?
Here is how Acumen Pharmaceuticals, Inc. (ABOS) and ADC Therapeutics SA (ADCT) have performed compared to their sector so far this year.
Zacks·16d ago
News Placeholder
ADC Therapeutics Eyes ZYNLONTA Expansion as LOTIS-5 Data Nears at H.C. Wainwright Chat
ADC Therapeutics (NYSE:ADCT) executives used a recent fireside chat at the H.C. Wainwright conference to outline the company's strategy to expand the reach of its CD19-directed antibody-drug...
MarketBeat·19d ago
News Placeholder
ADC Therapeutics (NYSE:ADCT) Shares Gap Up on Analyst Upgrade
ADC Therapeutics (NYSE:ADCT) Shares Gap Up Following Analyst Upgrade...
MarketBeat·22d ago
News Placeholder
ADC Therapeutics (NYSE:ADCT) Price Target Raised to $8.00
HC Wainwright boosted their target price on shares of ADC Therapeutics from $7.00 to $8.00 and gave the stock a "buy" rating in a research report on Monday...
MarketBeat·23d ago
News Placeholder
Heights Capital Management Inc. Has $1.31 Million Position in ADC Therapeutics SA $ADCT
Heights Capital Management Inc. lessened its holdings in ADC Therapeutics SA (NYSE:ADCT - Free Report) by 88.5% during the third quarter, according to the company in its most recent filing with the...
MarketBeat·28d ago
<
1
2
...
>

Latest ADCT News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.